CIK 0001390478
- Non-accelerated filer
- Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-200-5278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $716,682
- in 3 filings
Net −$716,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-01-29 | KRIEGSMAN STEVEN A Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2013-01-29 | Hillsberg Sanford Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2013-01-29 | Dunlap Ryan Principal Accounting Officer | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2012-12-31 | Ahn Mark J President & CEO | Other acquisition | +7,668 | $1.30 | $10K | 100,246 |
| 2012-12-31 | SCHWARTZ MARK W. EVP, Chief Operating Officer | Other acquisition | +7,668 | $1.30 | $10K | 462,688 |
| 2012-12-31 | Dunlap Ryan Principal Accounting Officer | Other acquisition | +1,246 | $1.30 | $2K | 1,246 |
| 2012-11-02 | Hillsberg Sanford Director | Gift | −20,000 | 136,376 | ||
| 2012-07-10 | SCHWARTZ MARK W. EVP Chief Operating Officer | Other acquisition | +21,902 | $0.40 | $9K | 461,809 |
| 2012-07-10 | Ahn Mark J President & CEO | Other acquisition | +31,289 | $0.40 | $12K | 92,578 |
| 2012-06-15 | SCHWARTZ MARK W. EVP Chief Operating Officer | Grant or award | +89,322 | 439,907 | ||
| 2012-06-15 | Hillsberg Sanford Director | Grant or award | +31,966 | 156,376 | ||
| 2012-06-15 | MAZANET ROSEMARY Chief Medical Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2012-01-12 | Hillsberg Sanford Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2012-01-12 | Nisi Rudolph Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2012-01-12 | Chin Richard Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2012-01-12 | GALLIKER STEPHEN S Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2012-01-12 | KRIEGSMAN STEVEN A Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2012-01-12 | SCHWARTZ MARK W. EVP Chief Operating Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2012-01-12 | Ahn Mark J President & CEO | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2011-12-31 | SCHWARTZ MARK W. EVP Chief Operating Officer | Other acquisition | +12,924 | $0.40 | $5K | 350,585 |
Page 19 of 29 · 580 trades